GATA3 as a Master Regulator and Therapeutic Target in Ovarian High-Grade Serous Carcinoma Stem Cells

International Journal of Cancer - United States
doi 10.1002/ijc.31750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma

2019English

HMGA2: A Biomarker Significantly Overexpressed in High-Grade Ovarian Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2010English

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Erratum To: Tubal Precursor Lesions in High Grade Serous Ovarian Carcinoma

Indian Journal of Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology
Oncology
2010English

Amplification of the Ch19p13.2 NACC1 Locus in Ovarian High-Grade Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2011English

Characteristics of 10-Year Survivors of High-Grade Serous Ovarian Carcinoma

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Retinoblastoma Pathway Deregulatory Mechanisms Determine Clinical Outcome in High-Grade Serous Ovarian Carcinoma

Modern Pathology
Forensic MedicinePathology
2013English

Clinico‑morphological Aspects and New Immunohistochemistry Characteristics of Ovarian High‑grade Serous Carcinoma

Archives of the Balkan Medical Union
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy